Resources
2024 Biosimilars Report
Cardinal Health recently announced the publication of the 2024 Biosimilars Report: insights on a pivotal year of evolution and expansion. In this year’s report, industry leaders weigh in on the economic, competitive, legislative and societal developments likely to have the biggest impact in 2024 and beyond. New research derived from surveys and expert interviews offer thought-provoking analyses, insights into market growth, drivers of biosimilars adoption and remaining barriers to widespread adoption. Access the Report Here
The report also contains articles on:
- In-depth analysis on a monumental year for biosimilars in 2023
- The evolving payer landscape
- Emerging best practices for managing biosimilar inventory
- How biosimilars are promoting access and healthcare system sustainability
- Ophthalmology survey results and trends
- The upcoming biosimilars pipeline
Cardinal Health Webinar
3 Ways to Strengthen Your Rheumatology Practice’s Revenue Cycle
A strong revenue cycle is key to your practice’s success. However, with complex treatment protocols, changes in regulatory and compliance standards and fluctuating reimbursements, navigating revenue cycle management is even more challenging for rheumatology practices.
With these challenges in mind, rheumatology practices are seeking tools to effectively manage their revenue cycle and avoid inaccurate claim submissions and denials or delays in reimbursement.
Delivered in partnership with NORM, this webinar will highlight best practices for strengthening your rheumatology practice’s revenue cycle, including ways to:
- Leverage robust analytics data and monitor key performance indicators
- Simplify payer contract negotiation and gain maximum reimbursements
- Streamline prior authorization and accelerate speed to therapy
Attendees will also hear from customers who have implemented tools to streamline revenue cycle management in their practices.
Watch our Recording to learn how to optimize your revenue cycle and drive practice efficiencies so you can focus on delivering high-quality patient care.
2023 Biosimilars Report
How will biosimilars impact the U.S. healthcare market in 2023? Cardinal Health researchers analyze new and changing perspectives of some of the most disruptive biosimilars launched in the areas of immunology and ophthalmology in the 2023 Biosimilars Report: tracking market expansion and sustainability amidst a shifting industry. Access the link here
Surveying more than 350 providers across rheumatology, ophthalmology, gastroenterology, and dermatology, this report offers new analysis, insights into market growth, drivers of adoption, and obstacles that remain. With an updated analysis of biosimilar market adoption and key milestones achieved throughout 2022, Cardinal Health experts discuss how policy and updated formulary announcements may impact patient access to these critical therapeutics.
Rheumatology Products Requiring Dilution Reference Guide
To access the “Rheumatology Products Requiring Dilution Reference Guide” Click Here
ISMP and ASHP Guidance
ISMP and ASHP have written some guidance for handling the current fluid and drug shortages and highlight some of the safety issues with trying to substitute fluids outside of package insert instructions that may be an additional helpful resource. Access the links below.
“Small Volume Parental Solutions Shortages” – ASHP: Click Here
“Management of Drug Shortages with 0.9% Sodium Chloride, Sterile Water for Injection and EPINEPHrine” -ISMP: Click Here
Understand your state’s laws for interchangeable biosimilars
Given the robust pipeline of Humira biosimilars and additional biosimilars with rheumatology indications that are anticipated to become FDA approved starting in 2023, it’s important to understand your own state’s laws on biologic interchangeability to prepare for this change. To help your practice navigate your state’s specific guidelines and support patients with biosimilar adoption, Cardinal Health collaborated with regulatory advisors to develop a state-by-state resource to help you understand the various biosimilar interchangeability laws. You can also access additional biosimilar related articles and resources to keep you up to date on the Cardinal Health Biosimilars website
Watch NORM and Cardinal Health’s April Webinar on Supply Shortage below!
Access the Recording Here
NORM Ventures 